Richard Bernstein Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Hold |
12,125
| – | – | 0.08% | 54 |
|
|
2025
Q4 | $2.77M | Sell |
12,125
-1,237
| -9% | -$282K | 0.08% | 40 |
|
|
2025
Q3 | $3.09M | Sell |
13,362
-19,310
| -59% | -$3.93M | 0.09% | 47 |
|
|
2025
Q2 | $6.06M | Sell |
32,672
-35
| -0.1% | -$6.5K | 0.15% | 51 |
|
|
2025
Q1 | $6.85M | Sell |
32,707
-1,519
| -4% | -$295K | 0.17% | 42 |
|
|
2024
Q4 | $6.08M | Hold |
34,226
| – | – | 0.14% | 52 |
|
|
2024
Q3 | $6.76M | Sell |
34,226
-2,377
| -6% | -$444K | 0.14% | 46 |
|
|
2024
Q2 | $6.28M | Buy |
36,603
+6
| +0% | +$994 | 0.14% | 50 |
|
|
2024
Q1 | $6.66M | Hold |
36,597
| – | – | 0.14% | 53 |
|
|
2023
Q4 | $5.67M | Buy |
36,597
+24
| +0.1% | +$3.5K | 0.13% | 55 |
|
|
2023
Q3 | $5.45M | Sell |
36,573
-35,982
| -50% | -$5.28M | 0.12% | 54 |
|
|
2023
Q2 | $9.78M | Hold |
72,555
| – | – | 0.21% | 36 |
|
|
2023
Q1 | $11.6M | Hold |
72,555
| – | – | 0.25% | 34 |
|
|
2022
Q4 | $11.7M | Hold |
72,555
| – | – | 0.26% | 38 |
|
|
2022
Q3 | $9.74M | Sell |
72,555
-6,703
| -8% | -$962K | 0.24% | 40 |
|
|
2022
Q2 | $12.1M | Buy |
79,258
+55,791
| +238% | +$8.53M | 0.26% | 41 |
|
|
2022
Q1 | $3.8M | Buy |
23,467
+11,331
| +93% | +$1.65M | 0.08% | 137 |
|
|
2021
Q4 | $1.64M | Hold |
12,136
| – | – | 0.03% | 219 |
|
|
2021
Q3 | $1.31M | Buy |
12,136
+2,287
| +23% | +$261K | 0.03% | 239 |
|
|
2021
Q2 | $1.11M | Hold |
9,849
| – | – | 0.02% | 242 |
|
|
2021
Q1 | $1.07M | Hold |
9,849
| – | – | 0.02% | 248 |
|
|
2020
Q4 | $1.05M | Hold |
9,849
| – | – | 0.03% | 235 |
|
|
2020
Q3 | $863K | Hold |
9,849
| – | – | 0.02% | 204 |
|
|
2020
Q2 | $966K | Hold |
9,849
| – | – | 0.03% | 202 |
|
|
2020
Q1 | $750K | Sell |
9,849
-43,172
| -81% | -$3.68M | 0.03% | 174 |
|
|
2019
Q4 | $4.69M | Hold |
53,021
| – | – | 0.15% | 97 |
|
|
2019
Q3 | $4.01M | Sell |
53,021
-8,129
| -13% | -$557K | 0.13% | 116 |
|
|
2019
Q2 | $4.45M | Hold |
61,150
| – | – | 0.15% | 100 |
|
|
2019
Q1 | $4.93M | Hold |
61,150
| – | – | 0.16% | 106 |
|
|
2018
Q4 | $5.64M | Hold |
61,150
| – | – | 0.21% | 77 |
|
|
2018
Q3 | $5.78M | Buy |
61,150
+53,409
| +690% | +$5.06M | 0.17% | 98 |
|
|
2018
Q2 | $717K | Buy |
7,741
+2,390
| +45% | +$233K | 0.02% | 292 |
|
|
2018
Q1 | $506K | Hold |
5,351
| – | – | 0.02% | 255 |
|
|
2017
Q4 | $518K | Buy |
+5,351
| New | +$504K | 0.02% | 205 |
|
|
2016
Q1 | – | Sell |
-64,999
| Closed | -$3.85M | – | 234 |
|
|
2015
Q4 | $3.85M | Hold |
64,999
| – | – | 0.49% | 78 |
|
|
2015
Q3 | $3.54M | Buy |
64,999
+5,324
| +9% | +$347K | 0.48% | 78 |
|
|
2015
Q2 | $4.01M | Buy |
+59,675
| New | +$3.9M | 0.48% | 86 |
|
Other funds holding ABBV
Richard Bernstein Advisors's ABBV Position: Q1 2026 in Review
Richard Bernstein Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 12,125 shares worth $2.64M. The position accounts for 0.08% of the portfolio, ranked #54.
Richard Bernstein Advisors first reported a position in ABBV in Q2 2015 and has held it in 37 quarters since. The position peaked at $12.1M in Q2 2022. 4,098 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Richard Bernstein Advisors held 12,125 shares of AbbVie worth $2.64M as of Q1 2026.
- Richard Bernstein Advisors left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 0.08% of Richard Bernstein Advisors's portfolio in Q1 2026, its #54 holding.
- Richard Bernstein Advisors first reported a position in AbbVie in Q2 2015 and has held it in 37 quarters since.
- Richard Bernstein Advisors's AbbVie position peaked at $12.1M in Q2 2022.
- 4,098 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Richard Bernstein Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.